öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÌ·ÓîÞ¥
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º483

ËùÊôԺУ£º¹ãÖÝÖÐÒ½Ò©´óѧ
ËùÊôԺϵ£º201»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ÖÐÎ÷Ò½½áºÏÖ×Áö·ÀÖÎÓëÒ©Àí
Ñо¿ÁìÓò£º ÖÐÎ÷Ò½½áºÏÖ×Áö·ÀÖÎÓëÒ©Àí [ÊÕÆð]




¸öÈ˼òÊö :
1966Äê4ÔÂÉú£¬¼®¹á¹ã¶«¶÷ƽ£¬²©Ê¿£¬Éú»¯½ÌÑÐÊÒÖ÷ÈΣ¬½ÌÊÚ¡£1995Äê10ÔÂÖÁ½ñÔÚ¹ãÖÝÖÐÒ½Ò©´óѧÉú»¯½ÌÑÐÊÒÈνÌ£¬ÖÐÎ÷Ò½½áºÏ»ù´¡öλÔÓéÀֵǼÈë¿ÚÏÂÔز©Ê¿µ¼Ê¦¡£ÈÎÖйúÉú»¯Óë·Ö×ÓÉúÎïѧѧ»áÖÐÒ½Ò©·Ö»á¸±Àíʳ¤¡£
Ñо¿·½ÏòΪÖÐÎ÷Ò½½áºÏÖ×Áö·ÀÖμ°Ö×Áö·Ö×ÓÒ©Àíѧ¡£½üÄêÖ÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿3Ïî¡¢¹ã¶«Ê¡¿Æ¼¼¼Æ»®2Ïî¡£µÚÒ»×÷Õß»òͨѶ×÷ÕßÔÚºËÐÄÆÚ¿¯·¢±íÑо¿ÂÛÎÄ30¶àƪ£¬ÔÚ¹ú¼ÊÆÚ¿¯·¢±íSCIÂÛÎÄ6ƪ¡£¸±Ö÷±à²Î±àÈ«¹úͳһ¹æ»®½Ì²Ä2²¿¡£Ö¸µ¼Ë¶Ê¿Ñо¿Éú±ÏÒµ14ÈË¡£

¿ÆÑй¤×÷ :
Ö÷ҪѧÊõÂÛÎÄ
£¨1£©XiaoJ,ZhangG,LiB,WuY,LiuX,TanY*.andDuB*.DioscinaugmentsHSV-tk-mediatedsuicidegenetherapyformelanomabypromotingconnexin-basedintercellularcommunication.Oncotarget.20178(1):798-807.IF=5.1
£¨2£©XiaoJ,LiY,ZhangW,JiangY,DuBandTanY*.miR-34binhibitsnasopharyngealcarcinomacellproliferationbytargetingubiquitin-specificpeptidase22.OncoTargetsTher.20169:1525-1534.IF=2.311
£¨3£©XiaoJ,QiuP,LaiX,HeP,WuY,DuBandTanY*.Cyclin-dependentkinase1inhibitorRO3306promotesmitoticslippageinpaclitaxel-treatedHepG2cells.Neoplasma.201461(1):41-47.IF=1.86
£¨4£©XiaoJ,ZhangG,QiuP,LiuX,WuY,DuB,LiJ,ZhouJandTanY*.TanshinoneIIAincreasesthebystandereffectofherpessimplexvirusthymidinekinase/ganciclovirgenetherapyviaenhancedgapjunctionalintercellularcommunication.PLoSOne.20138(7):e67662.IF=3.73
£¨5£©Li-HongZhu,WeiBi,Xiao-DongLiu,Jie-FenLi,Ying-YaWu,Biao-YanDuandYu-HuiTan*.InductionofapoptosisbyevodiamineinvolvesbothactivationofmitoticarrestandmitoticslippageONCOLOGY?REPORTS2011£¬26(6):?1447-1455.IF=1.84
(6).TanY,WeiX,ZhangW,WangX,WangK,DuBandXiaoJ*.ResveratrolenhancestheradiosensitivityofnasopharyngealcarcinomacellsbydownregulatingE2F1.OncolRep.201737£¨1£©:1833-1841.IF=2.6
(7).YuKou,LeiLi,HongLi,YuhuiTan,BinLi,KunWang,BiaoyanDu*.Berberinesuppressedepithelialmesenchymaltransitionthroughcross-talkregulationofPI3K/AKTandRAR¦Á/RAR¦Âinmelanomacells.BiochemBiophysResCommun.2016Sep14,479:290~296.
(8)ºÎÅàÓ¾£¬Ì·ÓîÞ¥£¨Í¨Ñ¶×÷Õߣ©,ÎâÓ³ÑÅ,ÕŹãÏ×,¶Å±êÑ×,Íõ½£,ÀîÒ©¾ÕÎâÜïÝǼîÁªºÏRO3306¶ÔÈ˸ΰ©Ï¸°ûHepG2µÄЭͬÒÖÖƹãÖÝÖÐÒ½Ò©´óѧѧ±¨2011£¬9Ô£¬28£¨5£©£º503-507.
(9)ÇðÅôÏè,ÕŹãÏ×,ÎâÓ³ÑÅ,Ф½¨ÓÂ,¶Å±êÑ×,¬Îıë,Ì·ÓîÞ¥£¨Í¨Ñ¶×÷Õߣ©µ¤²ÎËØÄƶÔСÊóºÚÉ«ËØÁöϸ°ûB16ϸ°û¼ä·ì϶Á¬½ÓµÄÓ°Ïì.¹ãÖÝÖÐÒ½Ò©´óѧѧ±¨2013,5£¬30£¨3£©£º363-366.
(10)³ÂÖ¾´Ó£¬¶Å±êÑ×£¬ÎâÓ³ÑÅ£¬ÕÅÎÄÒø£¬ÑîÐÛÓð£¬Àî¼ÎÃô£¬Ì·ÓîÞ¥£¨Í¨Ñ¶×÷Õߣ©µ¤²ÎͪIIA¶ÔHUVECϸ°û¼ä·ì϶Á¬½ÓµÄ×÷ÓùãÖÝÖÐÒ½Ò©´óѧѧ±¨£¬2016£¬3£¬33£¨2£©£º201-205Ö÷Òª1.×ó½ðÍèͨ¹ýµ÷ÖÆÖ×ÁöÌØÒì´úлÒָΰ©ºÍתÒƼ°»úÖÆÑо¿£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¨**£©£¬2018.1-2021.12£¬Ö÷³Ö£¬57Íò
2.»ùÓÚM-ArrestÓëM-slippage»úÖƵÄÖÐÒ©¸´·½³É·ÝÏàЭͬ¿¹Ö×ÁöÑо¿£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¨**£©£¬2010.1-2012.12£¬Ö÷³Ö£¬31Íò£»
3.ÖÐÒ©»îÐԳɷֶÔÖ×Áö×Ôɱ»ùÒòÅÔɱÉËЧӦÔöЧ×÷Óü°»úÀíÑо¿£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¨**£©£¬2007.1£­2009.12£¬Ö÷³Ö£¬28Íò£»
4.ÄÚƤ×æϸ°û½éµ¼Ö×Áö×Ôɱ»ùÒòÖÎÁƼ°µ¤²ÎÒûЭͬÔöЧÑо¿£¬¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿£¨2012B**£©2013.7£­2015.11£¬Ö÷³Ö£¬5Íò
5.×Ôɱ»ùÒòÅÔɱÉËЧӦÔöЧÖÐÒ©µÄɸÑ¡£¬¹ã¶«Ê¡¿Æ¼¼¼Æ»®£¨2005B**£©2006.1£­2009.1£¬Ö÷³Ö£¬5Íò

½ÌÓý±³¾° :
1988Äê±ÏÒµÓÚÖÐɽ´óѧÉúÎﻯѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñѧʿѧλ¡£
1991Äê±ÏÒµÓÚÖÐɽ´óѧÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñ˶ʿѧλ¡£
2005Äê±ÏÒµÓÚ¹ãÖÝÖÐÒ½Ò©´óѧÖÐÎ÷Ò½½áºÏ»ù´¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñ²©Ê¿Ñ§Î»¡£